Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.310
+0.050 (2.21%)
Aug 19, 2026, 9:51 AM EDT - Market open
Pulmonx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 87.44 | 90.5 | 83.79 | 68.68 | 53.66 | 48.42 | |
Revenue Growth | -3.43% | 8.01% | 22.01% | 27.98% | 10.84% | 47.91% |
Cost of Revenue | 20.06 | 23.36 | 21.79 | 17.92 | 13.8 | 12.79 |
Gross Profit | 67.38 | 67.14 | 62 | 50.75 | 39.87 | 35.63 |
Selling, General & Admin | 94.33 | 101.31 | 102.14 | 94.61 | 83.11 | 69.87 |
Research & Development | 19.36 | 19.49 | 15.85 | 18.08 | 15.4 | 13.06 |
Operating Expenses | 113.69 | 120.8 | 117.99 | 112.69 | 98.5 | 82.93 |
Operating Income | -46.31 | -53.66 | -55.99 | -61.94 | -58.64 | -47.3 |
Interest Expense | -3.77 | -3.16 | -3.51 | -3.23 | -1.07 | -0.83 |
Interest & Investment Income | 1.74 | 2.65 | 5.06 | 5.57 | 1.53 | 0.4 |
Currency Exchange Gain (Loss) | 0.4 | 0.7 | 0.1 | -0.8 | -0.4 | -0.59 |
Other Non Operating Income (Expenses) | 0.42 | 0.09 | 0.16 | 0.13 | - | - |
EBT Excluding Unusual Items | -47.52 | -53.38 | -54.18 | -60.27 | -58.57 | -48.32 |
Asset Writedown | - | - | -1.72 | - | - | - |
Pretax Income | -47.52 | -53.38 | -55.89 | -60.27 | -58.57 | -48.32 |
Income Tax Expense | 0.6 | 0.63 | 0.5 | 0.57 | 0.35 | 0.34 |
Net Income | -48.12 | -54 | -56.39 | -60.84 | -58.92 | -48.66 |
Net Income to Common | -48.12 | -54 | -56.39 | -60.84 | -58.92 | -48.66 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 42 | 41 | 39 | 38 | 37 | 36 |
Shares Outstanding (Diluted) | 42 | 41 | 39 | 38 | 37 | 36 |
Shares Change | 4.69% | 4.03% | 2.99% | 2.37% | 2.68% | 254.74% |
EPS (Basic) | -1.15 | -1.33 | -1.44 | -1.60 | -1.59 | -1.35 |
EPS (Diluted) | -1.15 | -1.33 | -1.44 | -1.60 | -1.59 | -1.35 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -30.67 | -32.83 | -32.98 | -38.42 | -46.4 | -45.06 |
Free Cash Flow Per Share | -0.74 | -0.81 | -0.84 | -1.01 | -1.25 | -1.25 |
Gross Margin | 77.06% | 74.19% | 74.00% | 73.90% | 74.29% | 73.59% |
Operating Margin | -52.96% | -59.30% | -66.82% | -90.19% | -109.27% | -97.70% |
Profit Margin | -55.03% | -59.67% | -67.31% | -88.60% | -109.80% | -100.51% |
Free Cash Flow Margin | -35.07% | -36.27% | -39.37% | -55.94% | -86.47% | -93.07% |
EBITDA | -45.49 | -52.61 | -54.49 | -60.39 | -57.12 | -46.44 |
EBITDA Margin | -52.02% | -58.13% | -65.04% | -87.93% | -106.45% | -95.91% |
D&A For EBITDA | 0.82 | 1.05 | 1.49 | 1.55 | 1.51 | 0.87 |
EBIT | -46.31 | -53.66 | -55.99 | -61.94 | -58.64 | -47.3 |
EBIT Margin | -52.96% | -59.30% | -66.82% | -90.19% | -109.27% | -97.70% |
Advertising Expenses | - | 10.1 | 7.9 | 4.8 | 6.1 | 5.1 |